CJC-1295 DAC
Caution, BioHarmony verdict
BioHarmony score 4.4 out of 10
CJC-1295 with DAC is the long-acting form, dosed about weekly, that keeps growth hormone elevated for 6 to 8 days. It has the most human pharmacology data of any CJC-1295 form, per Teichman 2006, but no human outcome trial, and its development was halted after a trial death never linked to the drug.
Read full reportWhat is CJC-1295 DAC?
CJC-1295 with DAC is the long-acting version of a lab-made peptide that tells your pituitary to release growth hormone, and the "DAC" is what makes it both distinctive and divisive. The Drug Affinity Complex binds the peptide to albumin in your blood, stretching its life to 6 to 8 days. Instead of the short, natural pulse the no-DAC form produces, it keeps growth hormone elevated continuously, a sustained "bleed." That buys once-weekly convenience, which is its main selling point.
From the BioHarmony report, reviewed Sep 19, 2026.
Saved on this device only.
Safety watch-outs
- Chest pain, severe headache, or a high blood-pressure reading: stop and seek care
- the cardiovascular risk cannot be reversed quickly with this form.
- Worsening reaction with each weekly dose (possible immune sensitization): stop immediately.
- Rising fasting glucose or HbA1c: stop and consult a clinician, especially with diabetes.
- Any active or suspected cancer: do not use
Full risk profile in the BioHarmony report.
Dosing as published
Source-reported figures only. This page does not calculate a personal dose.
No approved-label or study protocol is recorded for CJC-1295 DAC yet.
More reported protocols
MembersMembers can compare additional reported doses, schedules, and preparation notes.
Educator coverage (1)
Attributed viewpoints, separate from primary research.
- International Peptide Society 2018 Compound Curriculum Dr. William Seeds,
Trust & sourcing
- Last revieweddone
- Next reviewupcoming
FDA identifies immunogenicity and peptide-impurity concerns for compounded CJC-1295 and reports limited clinical data plus serious adverse events.
Primary sources
- Certain bulk drug substances for use in compounding that may present significant safety risks U.S. Food and Drug Administration,
Related peptides for recovery & tissue repair
- 7.4Thymosin Alpha-1Thymosin Alpha-1 is a 28-amino-acid thymic peptide with strongest evidence in immune-compromised and hospital-adjacent settings: Cao 2024 pooled 39 acute COPD…
- 7.2GHK-Cu (Copper Peptide)GHK-Cu is a human copper-binding tripeptide with the best evidence for topical skin repair and wound healing, including Mulder 1994 diabetic ulcer data showing 98.5%…
- 7.1SemaxSemax is a Russian-developed ACTH 4-7 + PGP heptapeptide with the strongest human signal in post-stroke recovery, including a 110-patient Gusev et al.
- 6.9Thymosin Beta-4 (Full)Thymosin beta-4 is the native 43-amino-acid peptide that promotes tissue repair via actin-sequestering and the Ac-SDKP repair axis.
The Ultimate Peptides Guide
Spot stronger candidates, weak evidence, and seller red flags before you buy.